Rodriguez Susan — SEC Form 4 filings
SEC reporting owner CIK 1812511. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-18 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 13,631 shares, $112,951 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 6,928 shares @ $8.75 ($60,594) in ARDELYX, INC., filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARDELYX, INC. (ARDX) | Chief Commercial Officer | 3 | — | 2 legs · 13,631 sh · $112,951 | 2 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 3 | — | — | 6 |
| Veradigm Inc. (MDRX) | Director | 3 | — | — | 3 |
| AVADEL PHARMACEUTICALS PLC (AVDL) | Chief Operating Officer | 2 | — | — | 2 |
| Monopar Therapeutics (MNPR) | CCSO | 1 | — | — | 1 |
Form 4 filings — Rodriguez Susan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-03 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 42,507 @ $0 | EDGAR |
| 2026-03-04 | 4 | Monopar Therapeutics (MNPR) | Grant/award (A): 48,728 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | AVADEL PHARMACEUTICALS PLC (AVDL) | Disposition to issuer (D): 300,000 (derivative) | EDGAR |
| 2025-06-03 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 46,512 @ $4.30 | EDGAR |
| 2025-05-13 | 4 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2024-06-20 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 42,106 @ $0 | EDGAR |
| 2024-05-23 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 6,703 @ $7.81 | EDGAR |
| 2024-02-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 6,928 @ $8.75 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 112,750 @ $0 · Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1812511 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →